Renal Function and Risk of Hip and Vertebral Fractures in Older Women
Overview
Authors
Affiliations
Background: An increased rate of hip fractures has been reported in patients with end-stage renal disease, but the effect of less severe renal dysfunction on fracture risk is uncertain.
Methods: We conducted a case-cohort study within a cohort of 9704 women 65 years or older to compare baseline renal function (estimated glomerular filtration rate [eGFR] using the Cockcroft-Gault equation) in 149 women who subsequently had hip fractures and 150 women who subsequently had vertebral fractures with eGRF in 396 randomly selected women.
Results: In models adjusted for age, weight, and calcaneal bone density, decreasing eGFR was associated with increased risk of hip fracture. Compared with women with an eGFR 60 mL/min per 1.73 m(2) or greater, the hazard ratio (95% confidence interval [CI]) for hip fracture was 1.57 (95% CI, 0.89-2.76) in those with an eGFR 45 to 59 mL/min per 1.73 m(2) and 2.32 (95% CI, 1.15-4.68) in those with an eGFR less than 45 mL/min per 1.73 m(2) (P for trend = .02). In particular, women with a reduced eGFR were at increased risk of trochanteric hip fracture (adjusted hazard ratio, 3.93 [95% CI, 1.37-11.30] in women with an eGFR 45-59 mL/min per 1.73 m(2) and 7.17 [95% CI, 1.93-26.67] in women with an eGFR <45 mL/min per 1.73 m(2); P for trend = .004). Renal function was not independently associated with risk of vertebral fracture (adjusted odds ratio, 1.08 [95% CI, 0.61-1.92] in women with an eGFR 45-59 mL/min per 1.73 m(2) and 1.33 [95% CI, 0.63-2.80] in women with an eGFR <45 mL/min per 1.73 m(2); P for trend = .47).
Conclusion: Older women with moderate renal dysfunction are at increased risk of hip fracture.
Imanishi Y, Taniuchi S, Kodama S, Yoshida H, Ito T, Kawai R Clin Exp Nephrol. 2024; 29(2):236-247.
PMID: 39402308 PMC: 11828842. DOI: 10.1007/s10157-024-02562-y.
Sato S, Sasabuchi Y, Okada A, Yasunaga H Br J Clin Pharmacol. 2024; 91(1):143-150.
PMID: 39245627 PMC: 11671314. DOI: 10.1111/bcp.16243.
Gifre L, Masso E, Fusaro M, Haarhaus M, Urena P, Cozzolino M Clin Kidney J. 2024; 17(8):sfae191.
PMID: 39099567 PMC: 11294886. DOI: 10.1093/ckj/sfae191.
Tamimi R, Bdair A, Shratih A, Abdalla M, Sarsour A, Hamdan Z PLoS One. 2024; 19(5):e0301814.
PMID: 38753845 PMC: 11098384. DOI: 10.1371/journal.pone.0301814.
Roles of Parathyroid Hormone and Fibroblast Growth Factor 23 in Advanced Chronic Kidney Disease.
Nakagawa Y, Komaba H Endocrinol Metab (Seoul). 2024; 39(3):407-415.
PMID: 38752265 PMC: 11220210. DOI: 10.3803/EnM.2024.1978.